NeuBase Therapeutics (STU:O7P) Accumulated Depreciation : €-0.20 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is NeuBase Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

NeuBase Therapeutics's quarterly accumulated depreciation increased from Mar. 2023 (€-1.45 Mil) to Jun. 2023 (€-1.61 Mil) but then stayed the same from Jun. 2023 (€-1.61 Mil) to Sep. 2023 (€-0.20 Mil).

NeuBase Therapeutics's annual accumulated depreciation increased from Sep. 2019 (€-0.02 Mil) to Sep. 2020 (€-0.14 Mil) and increased from Sep. 2020 (€-0.14 Mil) to Sep. 2021 (€-0.45 Mil).

NeuBase Therapeutics Accumulated Depreciation Historical Data

The historical data trend for NeuBase Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuBase Therapeutics Accumulated Depreciation Chart

NeuBase Therapeutics Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Accumulated Depreciation

Get a 7-Day Free Trial

-0.09

-0.02

-0.14

-0.45

NeuBase Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accumulated Depreciation	Get a 7-Day Free Trial															-1.31	-1.31	-1.45	-1.61	-0.20

NeuBase Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

NeuBase Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of NeuBase Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuBase Therapeutics (STU:O7P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

NBSE:USA O7P:Germany

Address

350 Technology Drive, Suite 421, Pittsburgh, PA, USA, 15219

Website

https://www.neubasetherapeutics.com

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

NeuBase Therapeutics (STU:O7P) Headlines

No Headlines